1. Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., et al. (2000).Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.Proceedings of the National Academy of Sciences of the United States of America,97(14), 8104–8109
2. Aboitiz, F., Ló pez, V., López-Calderó n, J., & Carrasco, X. (2006). Beyond endophenotypes: An interdisciplinary approach to attentional deficit-hyperactivity disorder. In M. Vanchevsky (Ed.),Focus in cognitive psychology research(pp. 183–205). New York: Nova Science Publishers
3. Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., et al. (1999).Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.Ameican Journal of Psychiatry,156(10), 1580–1589
4. Angrist, B., & Sudilovsky, A. (1978). Central nervous system stimulants: Historical aspects and clinical effects. In L. L. Iversen (Ed.),Handbook of psychopharmacology(Vol. 11, pp. 99–165).New York: Plenum Press
5. Arnsten, A. F. T. (2007). Catecholamine and second messenger influences on prefrontal cortical networks of “representational knowledge” A rational bridge between genetics and the symptoms of mental illness.Cerebral Cortex,17, i6–i15